{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:55:13Z","timestamp":1761310513059},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/coc.0b013e31816d1c94","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T07:10:36Z","timestamp":1222845036000},"page":"488-492","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of Central Vision and Macular Structure in Patients Undergoing Iodine-125 Brachytherapy for Ciliochoroidal Melanoma"],"prefix":"10.1097","volume":"31","author":[{"given":"Scott C. N.","family":"Oliver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan H.","family":"Kobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Y.","family":"Leu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa W.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley R.","family":"Straatsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jnci\/56.3.489","article-title":"Melanomas of the eye and other noncutaneous sites: epidemiologic aspects.","volume":"56","author":"Scotto","year":"1976","journal-title":"J Natl Cancer Inst"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. III. Initial mortality findings. COMS report no. 18.","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ophtha.2003.08.029","article-title":"Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.","volume":"111","year":"2004","journal-title":"Ophthalmology"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. V. Twelve-year mortality rates and prognostic factors. COMS report no. 28.","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report no. 16.","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0161-6420(99)90124-0","article-title":"Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.","volume":"106","author":"Finger","year":"1999","journal-title":"Ophthalmology"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s004170000208","article-title":"Phacoemulsification following treatment of choroidal melanoma.","volume":"238","author":"Wachtlin","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ophtha.2006.10.039","article-title":"Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS report no. 27.","volume":"114","year":"2007","journal-title":"Ophthalmology"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjo.2004.052159","article-title":"Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy.","volume":"89","author":"Finger","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archopht.1996.01100140299007","article-title":"Proliferative radiation retinopathy.","volume":"114","author":"Kinyoun","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ophtha.2004.09.028","article-title":"Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.","volume":"112","author":"Detorakis","year":"2005","journal-title":"Ophthalmology"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(93)90277-3","article-title":"High intensity 125-iodine (125I) plaque treatment of uveal melanoma.","volume":"26","author":"Quivey","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archopht.117.5.609","article-title":"Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma.","volume":"117","author":"Gunduz","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2356::AID-CNCR26>3.0.CO;2-V","article-title":"125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.","volume":"77","author":"Quivey","year":"1996","journal-title":"Cancer"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation.","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","article-title":"Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement.","volume":"127","author":"Gunduz","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00006982-200510000-00009","article-title":"Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.","volume":"25","author":"Shields","year":"2005","journal-title":"Retina"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00006982-200605000-00007","article-title":"Intravitreal triamcinolone acetonide for acute radiation papillopathy.","volume":"26","author":"Shields","year":"2006","journal-title":"Retina"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","article-title":"Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS report no. 3.","volume":"14","year":"1993","journal-title":"Control Clin Trials"},{"key":"R21-14-20210128","article-title":"Essentials of Low Vision Practice.","author":"Brilliant","year":"1999"},{"key":"R22-14-20210128","article-title":"COMS Manual of Procedures.","year":"1995"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. IV. Local treatment failure and enucleation in the first 5 years after brachytherapy: COMS report no. 19.","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bjo.69.2.136","article-title":"Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment.","volume":"69","author":"Della Sala","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/07853899809029936","article-title":"Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy.","volume":"30","author":"Verrotti","year":"1998","journal-title":"Ann Med"},{"key":"R26-14-20210128","first-page":"7","article-title":"Contrast sensitivity changes in background diabetic retinopathy.","volume":"26","author":"Khosla","year":"1991","journal-title":"Can J Ophthalmol"},{"key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00006324-200103000-00008","article-title":"Contrast sensitivity function in patients with impaired oral glucose tolerance.","volume":"78","author":"Gartaganis","year":"2001","journal-title":"Optom Vis Sci"},{"key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1475-1313.1994.tb00122.x","article-title":"Longitudinal study of visual functions in young insulin dependent diabetics.","volume":"14","author":"Banford","year":"1994","journal-title":"Ophthalmic Physiol Opt"},{"key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1444-0938.2003.tb03097.x","article-title":"Letter contrast sensitivity changes in early diabetic retinopathy.","volume":"86","author":"Stavrou","year":"2003","journal-title":"Clin Exp Optom"},{"key":"R30-14-20210128","first-page":"1819","article-title":"Contrast sensitivity loss is coupled with capillary dropout in patients with diabetes.","volume":"38","author":"Arend","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R31-14-20210128","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/bjo.87.6.747","article-title":"Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.","volume":"87","author":"Ong","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R32-14-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajo.2003.10.021","article-title":"Screening for sight-threatening diabetic retinopathy: comparison of fundus photography with automated color contrast threshold test.","volume":"137","author":"Ong","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0002-9394(88)90237-1","article-title":"Photocoagulation treatment of radiation retinopathy.","volume":"105","author":"Kinyoun","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"R34-14-20210128","first-page":"589","article-title":"Panretinal photocoagulation for radiation-induced ocular ischemia.","volume":"18","author":"Augsburger","year":"1987","journal-title":"Ophthalmic Surg"},{"key":"R35-14-20210128","first-page":"516","article-title":"Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation.","volume":"25","author":"Khosla","year":"1994","journal-title":"Ophthalmic Surg"},{"key":"R36-14-20210128","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1034\/j.1600-0420.2000.078006672.x","article-title":"Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation.","volume":"78","author":"Lovestam-Adrian","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1442-9071.2001.00361.x","article-title":"Contrast sensitivity following focal laser photocoagulation in clinically significant macular oedema due to diabetic retinopathy.","volume":"29","author":"Talwar","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.eye.6701637","article-title":"Photodynamic therapy for maculopathy due to radiation retinopathy.","volume":"19","author":"Bakri","year":"2005","journal-title":"Eye"},{"key":"R39-14-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1755-3768.2007.00899.x","article-title":"Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.","volume":"85","author":"Ziemssen","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"R40-14-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajo.2006.09.014","article-title":"Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy.","volume":"143","author":"Finger","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000421-200810000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:50:40Z","timestamp":1618033840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-200810000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31816d1c94","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}